NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals - 1 May 2023

Concepts

• pharmaceutical products
• national proprietary pharmaceuticals
• runcorn
• period of framework
• nhs framework agreement
• 01 - nhs framework agreement
• branded medicines - national tender lot
• 02 - nhs framework agreement
• branded medicines - national proprietary pharmaceuticals - 1 may
• branded medicines - national category tender lot

Location

Description

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 01 - Invitation to offer covering letter CM_PHR_22_5675 Document No. 01 - Invitation to offer covering letter CM_PHR_22_5675.docx Document No. 02 - Terms of offer Document No. 02 - Terms of offer.doc Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.pdf Document No. 05 - Selectt offer schedule instructions Document No. 05 - Selectt offer schedule instructions.docx Document No. 05a (i) Selectt Offer schedule - CM_PHR_22_5675_01 Document No. 05a (i) Selectt Offer schedule - CM_PHR_22_5675_01.xml Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.docx Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.pdf Document No. 05a (ii) Selectt Offer schedule - CM_PHR_22_5675_02 Document No. 05a (ii) Selectt Offer schedule - CM_PHR_22_5675_02.xml Document No. 05b (i) Tender Product listing and usage - CM_PHR_22_5675_01 Document No. 05b (i) Tender Product listing and usage - CM_PHR_22_5675_01.xlsx Document No. 05b (ii) Tender Product listing and usage - CM_PHR_22_5675_02 Document No. 05b (ii) Tender Product listing and usage - CM_PHR_22_5675_02.xlsx Document No. 05c - Volume discounts or Additional Products Offer Schedule Document No. 05c - Volume discounts or Additional Products Offer Schedule.xlsx Document No. 06 - Form of offer Document No. 06 - Form of offer.doc Document No. 07a - Quality control technical sheet Document No. 07a - Quality control technical sheet.pdf Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022 Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022.pdf Document No. 08 - Confidential information schedule Document No. 08 - Confidential information schedule.xls Document No. 09 - Tender design and instructions on completing the offer schedule Document No. 09 - Tender design and instructions on completing the offer schedule.doc Document No. 10 - Participating authorities Document No. 10 - Participating authorities.xlsx Document No. 00 - Read Me First Document 5675 Document No. 00 - Read Me First Document 5675.docx Document No. 05d - Supplementary usage data for Buprenorphine Methylphenidate and Oxycodone Document No. 05d - Supplementary usage data for Buprenorphine Methylphenidate and Oxycodone.xlsx